• Explore /
  • Poster
  • / Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.

Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.

Abstract Poster

Authors

Maysa Vilbert

Maysa Vilbert

University of Pittsburgh Medical Center, Pittsburgh, PA

Maysa Vilbert , Jonathan N Priantti , Thiago Madeira , Francisco Cezar A Moraes , Alireza Tojjari , Ibrahim Halil Sahin , Ludimila Cavalcante , Anwaar Saeed

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 366)

DOI

10.1200/JCO.2024.42.3_suppl.366

Abstract #

366

Poster Bd #

H8

Abstract Disclosures

Similar Posters

First Author: Mario Machado Lopes

First Author: Kohei Shitara

First Author: Xiaoting Ma

First Author: Yelena Y. Janjigian